AbbVie Filed Patent Suits To Delay Competition, Court Told

The patent lawsuits filed by AbbVie Inc. and Besins Healthcare Inc. over generic testosterone replacement treatments were “anti-competitive weapons” used to delay competition for the brand-name drug AndroGel, an attorney for...

Already a subscriber? Click here to view full article